` 570 (China Traditional Chinese Medicine Holdings Co Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

570
vs
Hang Seng (Hong Kong)

Over the past 12 months, has underperformed Hang Seng (Hong Kong), delivering a return of -54% compared to the Hang Seng (Hong Kong)'s 28% growth.

Stocks Performance
570 vs Hang Seng (Hong Kong)

Loading

Performance Gap
570 vs Hang Seng (Hong Kong)

Loading
570
Hang Seng (Hong Kong)
Difference

Performance By Year
570 vs Hang Seng (Hong Kong)

Loading
570
Hang Seng (Hong Kong)
Add Stock

Competitors Performance
China Traditional Chinese Medicine Holdings Co Ltd vs Peers

Hang Seng (Hong Kong)
570
LLY
JNJ
NOVO B
ROG
Add Stock

China Traditional Chinese Medicine Holdings Co Ltd
Glance View

Market Cap
10.1B HKD
Industry
Pharmaceuticals

China Traditional Chinese Medicine Holdings Co Ltd sits at the crossroads of ancient wisdom and modern commerce. Rooted deeply in the rich heritage of Traditional Chinese Medicine (TCM), this company skillfully crafts a range of products that cater to both domestic and international markets. At the core of its operations is the cultivation and processing of Chinese medicinal herbs, which are transformed into a wide portfolio of products, including ready-to-use TCM formula granules, patented medicines, and healthcare products. By leveraging its extensive network of cultivation bases, the company ensures the authenticity and quality of its raw materials, an essential component in a sector where the efficacy of products is deeply entwined with their origins. The company’s business model thrives on vertical integration, which allows it to exercise control over the entire supply chain—from the sourcing of raw materials to the manufacturing and distribution processes. Through this multifaceted approach, China Traditional Chinese Medicine Holdings Co Ltd maximizes its profit margins while maintaining stringent quality standards, crucial in a market where consumer trust is paramount. The firm's robust distribution network spans pharmacies, hospitals, and retail outlets, supplemented by a growing e-commerce presence. As healthcare trends increasingly lean towards natural and holistic remedies around the globe, the company finds itself well-positioned to not only cater to traditional markets but also to explore new opportunities in alternative medicine sectors worldwide.

Intrinsic Value
2.71 HKD
Undervaluation 26%
Intrinsic Value
Price
C
Back to Top